Suppr超能文献

透皮芬太尼贴剂所致严重腹泻的发生率:一种罕见事件。

The Incidence of Severe Diarrhea with Transdermal Fentanyl Patch: An Uncommon Event.

作者信息

Hemati Karim, Zadeh Poupak Rahim

机构信息

Associate Professor, Department of Anesthesia, Pain Fellowship, Ilam University of Medical Sciences , Ilam, Iran .

Associate Professor, Department of Anesthesia, Pain Fellowship, Iran University of Medical Sciences , Tehran, Iran .

出版信息

J Clin Diagn Res. 2015 Jun;9(6):UD01-2. doi: 10.7860/JCDR/2015/13194.6024. Epub 2015 Jun 1.

Abstract

Cancer pain is a major problem for the health care providers. One of the most important aspects of cancer pain is palliative care management. Recently, different research finding shows the efficacy of opioid analgesics such as fentanyl transdermal patch in chronic pain management. Transdermal Fentanyl patches may cause side effects such as drowsiness, dizziness, itching, life-threatening or serious breathing difficulties and diarrhea, mainly during the first 72 h of patient's treatment initiation and any time when the drug's dose is increased. We report three case reports of severe diarrhea without most common side effects associated with Fentanyl patches during first 72 h of patient's treatment.

摘要

癌症疼痛是医疗服务提供者面临的一个主要问题。癌症疼痛最重要的方面之一是姑息治疗管理。最近,不同的研究结果显示了阿片类镇痛药(如芬太尼透皮贴剂)在慢性疼痛管理中的疗效。芬太尼透皮贴剂可能会引起嗜睡、头晕、瘙痒、危及生命或严重的呼吸困难以及腹泻等副作用,主要发生在患者开始治疗的最初72小时内以及药物剂量增加的任何时候。我们报告了三例在患者治疗的最初72小时内出现严重腹泻但无芬太尼贴剂最常见副作用的病例报告。

相似文献

1
The Incidence of Severe Diarrhea with Transdermal Fentanyl Patch: An Uncommon Event.
J Clin Diagn Res. 2015 Jun;9(6):UD01-2. doi: 10.7860/JCDR/2015/13194.6024. Epub 2015 Jun 1.
2
Efficacy of fentanyl transdermal patch in the treatment of chronic soft tissue cancer pain.
Anesth Pain Med. 2015 Feb 19;5(1):e22900. doi: 10.5812/aapm.22900. eCollection 2015 Feb.
6
Benefit-risk assessment of transdermal fentanyl for the treatment of chronic pain.
Drug Saf. 2003;26(13):951-73. doi: 10.2165/00002018-200326130-00004.

本文引用的文献

1
Efficacy of fentanyl transdermal patch in the treatment of chronic soft tissue cancer pain.
Anesth Pain Med. 2015 Feb 19;5(1):e22900. doi: 10.5812/aapm.22900. eCollection 2015 Feb.
2
Pain management.
Ann Oncol. 2012 Sep;23 Suppl 10:x294-301. doi: 10.1093/annonc/mds360.
4
Practical considerations for optimal transdermal drug delivery.
Am J Health Syst Pharm. 2012 Jan 15;69(2):116-24. doi: 10.2146/ajhp110158.
5
Skin tolerability of transdermal patches.
Expert Opin Drug Deliv. 2011 Jul;8(7):939-48. doi: 10.1517/17425247.2011.574689. Epub 2011 Apr 21.
6
High-dose fentanyl patch for cancer pain of a patient with cholangiocarcinoma.
Korean J Intern Med. 2010 Sep;25(3):337-40. doi: 10.3904/kjim.2010.25.3.337. Epub 2010 Aug 31.
7
Evaluation of efficacy and safety of fentanyl transdermal patch (Durogesic D-TRANS) in chronic pain.
Acta Neurochir (Wien). 2011 Jan;153(1):181-90. doi: 10.1007/s00701-010-0785-4. Epub 2010 Sep 7.
8
Six- versus 12-h conversion method from intravenous to transdermal fentanyl in chronic cancer pain: a randomized study.
Support Care Cancer. 2011 May;19(5):691-5. doi: 10.1007/s00520-010-0890-1. Epub 2010 Jun 13.
9
Cancer pain and analgesia.
Ann N Y Acad Sci. 2008 Sep;1138:278-98. doi: 10.1196/annals.1414.033.
10
Psychological approaches to understanding and treating disease-related pain.
Annu Rev Psychol. 2005;56:601-30. doi: 10.1146/annurev.psych.56.091103.070302.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验